Dr. Reddy’s Outperformed BSE Healthcare Index


Dr. Reddy’s Laboratories has entered into an agreement with Integra Lifesciences to market and distribute DuraGen Plus and Saturable DuraGen Dural Regeneration in India.

The Company is looking forward to build its presence in the segment of regenerative technologies and making a difference to the lives of patients undergoing neurosurgery.

The BSE Healthcare index closed in red, lower by 0.8%, while the stock closed higher by 0.8% at Rs 2644 per share in Monday’s trade on BSE. Major pharma stocks such as Sun Pharma, Lupin, Aurobindo Pharma, Glenmark and Cipla also closed with weak performance in Monday’s trading session.

The major indices in the market, Nifty and Sensex, closed lower by 187 points and 62 points respectively. 

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 
Give a Missed Call for Free Trial - 09699997717 
Share on Google Plus

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

0 comments: